DaVita Inc. Reports Q3 Earnings

DENVER – DaVita Inc. (NYSE:DVA) reported third quarter earnings that fell short of analyst expectations, sending shares plunging 17% in after-hours trading on Tuesday.

The kidney dialysis provider posted adjusted earnings per share of $2.59, missing the consensus estimate of $2.72. Revenue came in slightly ahead at $3.26 billion versus expectations of $3.25 billion.

> "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said CEO Javier Rodriguez.

For the quarter, DaVita's U.S. dialysis segment saw operating income of $549 million on revenue of $2.91 billion. The company performed 7.35 million dialysis treatments, representing a 0.1% decrease from the previous quarter.

DaVita repurchased 2.7 million shares during Q3 at an average price of $147.20 per share. The company ended the quarter with $1.07 billion in cash and cash equivalents.

Looking ahead, DaVita reaffirmed its full-year 2024 guidance for adjusted operating income between $1.91 billion and $2.01 billion. The company expects adjusted diluted earnings per share of $9.25 to $10.05.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.